Remuneration of participants in clinical research: reflections based on the Constitution

Authors

  • Aline Albuquerque
  • Heloisa Helena Barboza

Abstract

While Resolution CNS 466/2012 establishes the possibility of the participants in Phase I clinical research or bioequivalence receiving payment, the Federal Constitution of 1988 absolutely prohibits the commercialization of the human body. This ethical and legal study aims to analyze the unpaid participation of individuals in research in the light of an international theoretical framework and the Brazilian Constitution. We conclude that there is no international consensus on what payment would represent “undue inducement”, especially if we consider that there are people who live on the margins of the poverty line, particularly in Brazil. Considering the constitutional rule concerning the prohibition of all kinds of commercialization of the human body, this text supports the ethical and legal inadequacy of the device Resolution CNS 466/2012.

Keywords:

Research. Payment. Resolution 466/12. Federal Constitution.
Vol. 24 No. 1 (2016): Rev. bioét. (Impr.). 2016; 24 (1)

Published:

2016-03-29

Downloads

How to Cite

1.
Albuquerque A, Barboza HH. Remuneration of participants in clinical research: reflections based on the Constitution. Rev. bioét.(Impr.). [Internet]. 2016 Mar. 29 [cited 2024 May 14];24(1). Available from: https://revistabioetica.cfm.org.br/revista_bioetica/article/view/1061